Does LEUPROLIDE Cause Product packaging issue? 20 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Product packaging issue have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.0% of all adverse event reports for LEUPROLIDE.
20
Reports of Product packaging issue with LEUPROLIDE
0.0%
of all LEUPROLIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging issue From LEUPROLIDE?
Of the 20 reports.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which LEUPROLIDE Alternatives Have Lower Product packaging issue Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM